Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 42 entries
Sorted by: Best Match Show Resources per page
The catalytic activity of the inactive conformation of delta-chymotrypsin.

FEBS letters

Fersht AR.
PMID: 11946933
FEBS Lett. 1973 Feb 01;29(3):283-285. doi: 10.1016/0014-5793(73)80039-0.

No abstract available.

Cite
Fersht AR. The catalytic activity of the inactive conformation of delta-chymotrypsin. FEBS Lett. 1973;29(3):283-285doi: 10.1016/0014-5793(73)80039-0.
Fersht, A. R. (1973). The catalytic activity of the inactive conformation of delta-chymotrypsin. FEBS letters, 29(3), 283-285. https://doi.org/10.1016/0014-5793(73)80039-0
Fersht, A R.. "The catalytic activity of the inactive conformation of delta-chymotrypsin." FEBS letters vol. 29,3 (1973): 283-285. doi: https://doi.org/10.1016/0014-5793(73)80039-0
Fersht AR. The catalytic activity of the inactive conformation of delta-chymotrypsin. FEBS Lett. 1973 Feb 01;29(3):283-285. doi: 10.1016/0014-5793(73)80039-0. PMID: 11946933.
Copy Download .nbib Format: NLM
Therapeutic hypothermia in severe hypoxic-ischemic encephalopathy: a cost-effectiveness analysis.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Packer CH, Hersh AR, Sargent JA, Caughey AB.
PMID: 32156180
J Matern Fetal Neonatal Med. 2020 Mar 10;1-8. doi: 10.1080/14767058.2020.1733519. Epub 2020 Mar 10.

No abstract available.

Cite
Packer CH, Hersh AR, Sargent JA, et al. Therapeutic hypothermia in severe hypoxic-ischemic encephalopathy: a cost-effectiveness analysis. J Matern Fetal Neonatal Med. 2020;1-8doi: 10.1080/14767058.2020.1733519.
Packer, C. H., Hersh, A. R., Sargent, J. A., & Caughey, A. B. (2020). Therapeutic hypothermia in severe hypoxic-ischemic encephalopathy: a cost-effectiveness analysis. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-8. https://doi.org/10.1080/14767058.2020.1733519
Packer, Claire H, et al. "Therapeutic hypothermia in severe hypoxic-ischemic encephalopathy: a cost-effectiveness analysis." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2020): 1-8. doi: https://doi.org/10.1080/14767058.2020.1733519
Packer CH, Hersh AR, Sargent JA, Caughey AB. Therapeutic hypothermia in severe hypoxic-ischemic encephalopathy: a cost-effectiveness analysis. J Matern Fetal Neonatal Med. 2020 Mar 10;1-8. doi: 10.1080/14767058.2020.1733519. Epub 2020 Mar 10. PMID: 32156180.
Copy Download .nbib Format: NLM
Straightforward Access to the Nitric Oxide Donor Azasydnone Scaffold by Cascade Reactions of Amines.

Chemistry (Weinheim an der Bergstrasse, Germany)

Zhilin ES, Bystrov DM, Ananyev IV, Fershtat LL, Makhova NN.
PMID: 31508851
Chemistry. 2019 Nov 13;25(63):14284-14289. doi: 10.1002/chem.201903526. Epub 2019 Oct 17.

A novel one-pot cascade method for the assembly of valuable NO-donor azasydnone scaffold has been developed. The construction strategy involves a diazotization/azo coupling/elimination/double rearrangement cascade sequence of readily available amines. The current protocol enables the generation of a diverse...

Cite
Zhilin ES, Bystrov DM, Ananyev IV, et al. Straightforward Access to the Nitric Oxide Donor Azasydnone Scaffold by Cascade Reactions of Amines. Chemistry. 2019;25(63):14284-14289doi: 10.1002/chem.201903526.
Zhilin, E. S., Bystrov, D. M., Ananyev, I. V., Fershtat, L. L., & Makhova, N. N. (2019). Straightforward Access to the Nitric Oxide Donor Azasydnone Scaffold by Cascade Reactions of Amines. Chemistry (Weinheim an der Bergstrasse, Germany), 25(63), 14284-14289. https://doi.org/10.1002/chem.201903526
Zhilin, Egor S, et al. "Straightforward Access to the Nitric Oxide Donor Azasydnone Scaffold by Cascade Reactions of Amines." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 25,63 (2019): 14284-14289. doi: https://doi.org/10.1002/chem.201903526
Zhilin ES, Bystrov DM, Ananyev IV, Fershtat LL, Makhova NN. Straightforward Access to the Nitric Oxide Donor Azasydnone Scaffold by Cascade Reactions of Amines. Chemistry. 2019 Nov 13;25(63):14284-14289. doi: 10.1002/chem.201903526. Epub 2019 Oct 17. PMID: 31508851.
Copy Download .nbib Format: NLM
Folding and binding.

Current opinion in structural biology

Dill KA, Fersht AR.
PMID: 8794135
Curr Opin Struct Biol. 1996 Feb 01;6(1):1-2. doi: 10.1016/s0959-440x(96)80087-x.

No abstract available.

Cite
Dill KA, Fersht AR. Folding and binding. Curr Opin Struct Biol. 1996;6(1):1-2doi: 10.1016/s0959-440x(96)80087-x.
Dill, K. A., & Fersht, A. R. (1996). Folding and binding. Current opinion in structural biology, 6(1), 1-2. https://doi.org/10.1016/s0959-440x(96)80087-x
Dill, and Fersht. "Folding and binding." Current opinion in structural biology vol. 6,1 (1996): 1-2. doi: https://doi.org/10.1016/s0959-440x(96)80087-x
Dill KA, Fersht AR. Folding and binding. Curr Opin Struct Biol. 1996 Feb 01;6(1):1-2. doi: 10.1016/s0959-440x(96)80087-x. PMID: 8794135.
Copy Download .nbib Format: NLM
A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective.

JAMA pediatrics

DeMartino P, Haag MB, Hersh AR, Caughey AB, Roth JA.
PMID: 33749717
JAMA Pediatr. 2021 Jun 01;175(6):617-623. doi: 10.1001/jamapediatrics.2020.7140.

IMPORTANCE: Hundreds of gene therapies are undergoing clinical testing and are likely to be priced more than $1 million per course of treatment. The association that high prices will have with insurance coverage of gene therapy remains unclear. Gene...

Cite
DeMartino P, Haag MB, Hersh AR, et al. A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective. JAMA Pediatr. 2021;175(6):617-623doi: 10.1001/jamapediatrics.2020.7140.
DeMartino, P., Haag, M. B., Hersh, A. R., Caughey, A. B., & Roth, J. A. (2021). A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective. JAMA pediatrics, 175(6), 617-623. https://doi.org/10.1001/jamapediatrics.2020.7140
DeMartino, Patrick, et al. "A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective." JAMA pediatrics vol. 175,6 (2021): 617-623. doi: https://doi.org/10.1001/jamapediatrics.2020.7140
DeMartino P, Haag MB, Hersh AR, Caughey AB, Roth JA. A Budget Impact Analysis of Gene Therapy for Sickle Cell Disease: The Medicaid Perspective. JAMA Pediatr. 2021 Jun 01;175(6):617-623. doi: 10.1001/jamapediatrics.2020.7140. PMID: 33749717; PMCID: PMC7985816.
Copy Download .nbib Format: NLM
Maternal and infant hospitalization costs associated with maternal pre-pregnancy body mass index in California, 2007-2011.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Mischkot BF, Hersh AR, Greiner KS, Garg B, Caughey AB.
PMID: 33261530
J Matern Fetal Neonatal Med. 2020 Dec 01;1-10. doi: 10.1080/14767058.2020.1852207. Epub 2020 Dec 01.

BACKGROUND: In the United States, the number of pregnant women who are overweight or obese is increasing. While such individuals are at increased risk of pregnancy complications, data regarding costs associated with pre-pregnancy body mass index (BMI) and maternal...

Cite
Mischkot BF, Hersh AR, Greiner KS, et al. Maternal and infant hospitalization costs associated with maternal pre-pregnancy body mass index in California, 2007-2011. J Matern Fetal Neonatal Med. 2020;1-10doi: 10.1080/14767058.2020.1852207.
Mischkot, B. F., Hersh, A. R., Greiner, K. S., Garg, B., & Caughey, A. B. (2020). Maternal and infant hospitalization costs associated with maternal pre-pregnancy body mass index in California, 2007-2011. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-10. https://doi.org/10.1080/14767058.2020.1852207
Mischkot, Brooke F, et al. "Maternal and infant hospitalization costs associated with maternal pre-pregnancy body mass index in California, 2007-2011." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2020): 1-10. doi: https://doi.org/10.1080/14767058.2020.1852207
Mischkot BF, Hersh AR, Greiner KS, Garg B, Caughey AB. Maternal and infant hospitalization costs associated with maternal pre-pregnancy body mass index in California, 2007-2011. J Matern Fetal Neonatal Med. 2020 Dec 01;1-10. doi: 10.1080/14767058.2020.1852207. Epub 2020 Dec 01. PMID: 33261530.
Copy Download .nbib Format: NLM
Recent Advances in the Synthesis and Biomedical Applications of Heterocyclic NO-Donors.

Molecules (Basel, Switzerland)

Fershtat LL, Zhilin ES.
PMID: 34577175
Molecules. 2021 Sep 21;26(18). doi: 10.3390/molecules26185705.

Nitric oxide (NO) is a key signaling molecule that acts in various physiological processes such as cellular metabolism, vasodilation and transmission of nerve impulses. A wide number of vascular diseases as well as various immune and neurodegenerative disorders were...

Cite
Fershtat LL, Zhilin ES. Recent Advances in the Synthesis and Biomedical Applications of Heterocyclic NO-Donors. Molecules. 2021;26(18)doi: 10.3390/molecules26185705.
Fershtat, L. L., & Zhilin, E. S. (2021). Recent Advances in the Synthesis and Biomedical Applications of Heterocyclic NO-Donors. Molecules (Basel, Switzerland), 26(18), . https://doi.org/10.3390/molecules26185705
Fershtat, Leonid L, and Zhilin, Egor S. "Recent Advances in the Synthesis and Biomedical Applications of Heterocyclic NO-Donors." Molecules (Basel, Switzerland) vol. 26,18 (2021). doi: https://doi.org/10.3390/molecules26185705
Fershtat LL, Zhilin ES. Recent Advances in the Synthesis and Biomedical Applications of Heterocyclic NO-Donors. Molecules. 2021 Sep 21;26(18). doi: 10.3390/molecules26185705. PMID: 34577175; PMCID: PMC8470015.
Copy Download .nbib Format: NLM
Cost-effectiveness of influenza vaccination during pregnancy.

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians

Chaiken SR, Hersh AR, Zimmermann MS, Ameel BM, Layoun VR, Caughey AB.
PMID: 33478281
J Matern Fetal Neonatal Med. 2021 Jan 21;1-17. doi: 10.1080/14767058.2021.1876654. Epub 2021 Jan 21.

OBJECTIVE: To assess the cost-effectiveness of influenza vaccination for all pregnant patients in the United States.METHODS: We designed a cost-effectiveness model to compare outcomes and costs in pregnant patients who received the inactivated, trivalent influenza vaccine to those who...

Cite
Chaiken SR, Hersh AR, Zimmermann MS, et al. Cost-effectiveness of influenza vaccination during pregnancy. J Matern Fetal Neonatal Med. 2021;1-17doi: 10.1080/14767058.2021.1876654.
Chaiken, S. R., Hersh, A. R., Zimmermann, M. S., Ameel, B. M., Layoun, V. R., & Caughey, A. B. (2021). Cost-effectiveness of influenza vaccination during pregnancy. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 1-17. https://doi.org/10.1080/14767058.2021.1876654
Chaiken, Sarina R, et al. "Cost-effectiveness of influenza vaccination during pregnancy." The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians vol. (2021): 1-17. doi: https://doi.org/10.1080/14767058.2021.1876654
Chaiken SR, Hersh AR, Zimmermann MS, Ameel BM, Layoun VR, Caughey AB. Cost-effectiveness of influenza vaccination during pregnancy. J Matern Fetal Neonatal Med. 2021 Jan 21;1-17. doi: 10.1080/14767058.2021.1876654. Epub 2021 Jan 21. PMID: 33478281.
Copy Download .nbib Format: NLM
Retraction. Directed evolution of new catalytic activity using the alpha/beta-barrel scaffold.

Nature

Altamirano MM, Blackburn JM, Aguayo C, Fersht AR.
PMID: 12024219
Nature. 2002 May 23;417(6887):468. doi: 10.1038/417468a.

No abstract available.

Cite
Altamirano MM, Blackburn JM, Aguayo C, et al. Retraction. Directed evolution of new catalytic activity using the alpha/beta-barrel scaffold. Nature. 2002;417(6887):468doi: 10.1038/417468a.
Altamirano, M. M., Blackburn, J. M., Aguayo, C., & Fersht, A. R. (2002). Retraction. Directed evolution of new catalytic activity using the alpha/beta-barrel scaffold. Nature, 417(6887), 468. https://doi.org/10.1038/417468a
Altamirano, M M, et al. "Retraction. Directed evolution of new catalytic activity using the alpha/beta-barrel scaffold." Nature vol. 417,6887 (2002): 468. doi: https://doi.org/10.1038/417468a
Altamirano MM, Blackburn JM, Aguayo C, Fersht AR. Retraction. Directed evolution of new catalytic activity using the alpha/beta-barrel scaffold. Nature. 2002 May 23;417(6887):468. doi: 10.1038/417468a. PMID: 12024219.
Copy Download .nbib Format: NLM
Nimodipine in the treatment of dementia.

Drugs of today (Barcelona, Spain : 1998)

Ferszt R, Kanowski S.
PMID: 14988753
Drugs Today (Barc). 1998 Sep;34(9):767-76. doi: 10.1358/dot.1998.34.9.485275.

No abstract available.

Cite
Ferszt R, Kanowski S. Nimodipine in the treatment of dementia. Drugs Today (Barc). 1998;34(9):767-76doi: 10.1358/dot.1998.34.9.485275.
Ferszt, R., & Kanowski, S. (1998). Nimodipine in the treatment of dementia. Drugs of today (Barcelona, Spain : 1998), 34(9), 767-76. https://doi.org/10.1358/dot.1998.34.9.485275
Ferszt, R, and Kanowski, S. "Nimodipine in the treatment of dementia." Drugs of today (Barcelona, Spain : 1998) vol. 34,9 (1998): 767-76. doi: https://doi.org/10.1358/dot.1998.34.9.485275
Ferszt R, Kanowski S. Nimodipine in the treatment of dementia. Drugs Today (Barc). 1998 Sep;34(9):767-76. doi: 10.1358/dot.1998.34.9.485275. PMID: 14988753.
Copy Download .nbib Format: NLM
Assembly of Tetrazolylfuroxan Organic Salts: Multipurpose Green Energetic Materials with High Enthalpies of Formation and Excellent Detonation Performance.

Chemistry (Weinheim an der Bergstrasse, Germany)

Larin AA, Muravyev NV, Pivkina AN, Suponitsky KY, Ananyev IV, Khakimov DV, Fershtat LL, Makhova NN.
PMID: 30644611
Chemistry. 2019 Mar 15;25(16):4225-4233. doi: 10.1002/chem.201806378. Epub 2019 Feb 19.

A series of highly energetic organic salts comprising a tetrazolylfuroxan anion, explosophoric azido or azo functionalities, and nitrogen-rich cations were synthesized by simple, efficient, and scalable chemical routes. These energetic materials were fully characterized by IR and multinuclear NMR...

Cite
Larin AA, Muravyev NV, Pivkina AN, et al. Assembly of Tetrazolylfuroxan Organic Salts: Multipurpose Green Energetic Materials with High Enthalpies of Formation and Excellent Detonation Performance. Chemistry. 2019;25(16):4225-4233doi: 10.1002/chem.201806378.
Larin, A. A., Muravyev, N. V., Pivkina, A. N., Suponitsky, K. Y., Ananyev, I. V., Khakimov, D. V., Fershtat, L. L., & Makhova, N. N. (2019). Assembly of Tetrazolylfuroxan Organic Salts: Multipurpose Green Energetic Materials with High Enthalpies of Formation and Excellent Detonation Performance. Chemistry (Weinheim an der Bergstrasse, Germany), 25(16), 4225-4233. https://doi.org/10.1002/chem.201806378
Larin, Alexander A, et al. "Assembly of Tetrazolylfuroxan Organic Salts: Multipurpose Green Energetic Materials with High Enthalpies of Formation and Excellent Detonation Performance." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 25,16 (2019): 4225-4233. doi: https://doi.org/10.1002/chem.201806378
Larin AA, Muravyev NV, Pivkina AN, Suponitsky KY, Ananyev IV, Khakimov DV, Fershtat LL, Makhova NN. Assembly of Tetrazolylfuroxan Organic Salts: Multipurpose Green Energetic Materials with High Enthalpies of Formation and Excellent Detonation Performance. Chemistry. 2019 Mar 15;25(16):4225-4233. doi: 10.1002/chem.201806378. Epub 2019 Feb 19. PMID: 30644611.
Copy Download .nbib Format: NLM
How and why to publish in PNAS.

Proceedings of the National Academy of Sciences of the United States of America

Fersht A.
PMID: 16576766
Proc Natl Acad Sci U S A. 2005 May 03;102(18):6241-2. doi: 10.1073/pnas.0502713102.

No abstract available.

Cite
Fersht A. How and why to publish in PNAS. Proc Natl Acad Sci U S A. 2005;102(18):6241-2doi: 10.1073/pnas.0502713102.
Fersht, A. (2005). How and why to publish in PNAS. Proceedings of the National Academy of Sciences of the United States of America, 102(18), 6241-2. https://doi.org/10.1073/pnas.0502713102
Fersht, Alan. "How and why to publish in PNAS." Proceedings of the National Academy of Sciences of the United States of America vol. 102,18 (2005): 6241-2. doi: https://doi.org/10.1073/pnas.0502713102
Fersht A. How and why to publish in PNAS. Proc Natl Acad Sci U S A. 2005 May 03;102(18):6241-2. doi: 10.1073/pnas.0502713102. PMID: 16576766; PMCID: PMC1088396.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 42 entries